CDT Equity Inc. (CDT) Research

Based in Naples, Florida, CDT Equity, Inc. commenced operations in October 2021. This firm, co-founded by David Joszef Tapolczay and Freda C. Lewis-Hall, focuses on aiding the advancement and market entry of clinical-stage medical innovations.

Market snapshot

Symbol
CDT
Price
$1.02
Day change
+47.19%
Market cap
$5.0M
P/E ratio
0.00x
52-week range
0.671-610
Sector
Healthcare
Industry
Biotechnology

Recent news

  • CDT Equity Stock Gets A Boost On SarborgQ Development News

    CDT Equity Inc. (NASDAQ:CDT) shares are soaring Thursday after the company highlighted a new fundraising round completed by Sarborg Limited, a firm in which CDT holds 1,020 shares. The proceeds will support the launch of SarborgQ.

  • What's Going On With CDT Equity Shares On Monday?

    • CDT Equity stock is among today's top performers. What's behind CDT gains?

Peer companies

  • Concord Medical Services Holdings Limited (CCM)
  • Envoy Medical, Inc. (COCH)
  • Enveric Biosciences, Inc. (ENVB)
  • Hepion Pharmaceuticals, Inc. (HEPA)
  • Lixte Biotechnology Holdings, Inc. (LIXT)
  • NewGenIvf Group Limited (NIVF)
  • Petros Pharmaceuticals, Inc. (PTPI)
  • SCWorx Corp. (WORX)

Recent insider activity

  • Regan Andrew — A-Award (100000 shares) on 2026-05-13
  • Regan Andrew — A-Award (147401 shares) on 2026-03-24
  • Regan Andrew — C-Conversion (147401 shares) on 2026-03-24
  • Olsen Ulrik K — trade (0 shares) on 2026-04-27
  • Taylor Mark Andrew — J-Other (51420358 shares) on 2026-03-17

Open CDT Equity Inc. (CDT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.